| Gene symbol | CD19 | Synonyms | B4, CVID3 | Type of gene | protein-coding |
| Chromosome | 16 | Map location | 16p11.2 | dbXrefs | |
| Description | CD19 molecule | ||||
| GTO ID | GTC1587 |
| Trial ID | NCT02672501 |
| Disease | B-Cell Leukemia |
| Altered gene | CD19 |
| Therapeutic/Target gene | Target gene |
| Therapy | CAR-T cell |
| Treatment | CD19 CAR-T cells |
| Generation | 2nd |
| Phase | Phase1|Phase2 |
| Recruitment status | Unknown |
| Title | A Study to Assess CD19-targeted Immunotherapy T Cells in Patients With Relapsed or Refractory CD19+ B Cell Leukemia |
| Year | 2016 |
| Country | China |
| Company sponsor | Shanghai GeneChem Co., Ltd. |
| Other ID(s) | Genechem |
| Vector information | |||||
|
|||||
| Cohort 1 | |||||||||
|
|||||||||